Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Astellas Scientific & Medical Affairs, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosed with OAB (with or without urgency incontinence) by the treating HCP, with symptoms for at least three months prior to study enrollment
Initiating a new course of treatment with mirabegron or antimuscarinic medication (including patch formulation) for OAB, which may be first course of any treatment for OAB, restart or switch from one drug to another
Willing and able to complete PRO questionnaires with minimal assistance
You may not be if
Current participation in clinical trials of OAB
Use of more than one OAB medication at time of enrollment
Patients whose OAB has been treated with onabotulinumtoxinA, sacral neuromodulation, percutaneous tibial nerve stimulation, external beam radiation (XRT), stents, surgery, or intermittent catheterization prior to or at time of enrollment
Neurologic conditions associated with OAB symptoms
Patients residing in a nursing home
Clareo Health | A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)
